MedTrace Logo

Biomarker Feedback to Motivate Tobacco Cessation in Pregnant Alaska Native Women

NCT01605643 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2017-12-19

No results posted yet for this study

Summary

Use of tobacco is very high among Alaska Native women. The investigators are conducting a three phase study. The first phase will examine biomarkers of tobacco exposure in pregnant women and their newborns. The second phase is a qualitative study to translate the biomarker findings into intervention messages. The third phase is a pilot of the biomarker feedback intervention compared with a control condition.

Conditions

  • Cancer
  • Tobacco Use
  • Pregnancy

Sponsors & Collaborators

Principal Investigators

  • Christi A Patten, PhD · Mayo Clinic

Eligibility

Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2017-06-30
Completion
2017-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01605643 on ClinicalTrials.gov